Develops clinical and PRE-clinical neurokinin receptor antagonists
NeRRe Therapeutics has raised €14M across 1 funding round from 3 investors, most recently a Series A round in Dec 2012. Based in Hertford, UK; founded 2012; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2012-12-01 | Series A | €14M |
| Advent Venture Partners,Novo A,S |
| View deal → |
